Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure allows for selective modification, making it valuable in creating compounds with central nervous system activity. Commonly employed in medicinal chemistry for constructing drug candidates targeting neurological disorders and inflammation, such as Alzheimer's disease or depression. The hydroxyethyl group enables further functionalization or conjugation, enhancing solubility and bioavailability in final drug forms. Additionally, it is used in organic chemistry to protect amino groups in multi-step syntheses, as the tert-butyl carbamate (Boc) group can be selectively introduced and removed without affecting other molecular structures.